Canopy Biosciences

Spatial multi-omics solutions for accelerating life science research and discovery

placeSt. Louis, Missouri, United States calendar_todayFounded 2016 groups50 employees language canopybiosciences.com

Innovation

3 patent families (2 granted) — focus: Electricity & electronics, Physics & computing, Chemistry & metallurgy; filing pace accelerating. Cited 128 times.

YearFilings
20201
20212
20222
20231
20243
20253
20261

Investor mix

8 investors on record; lead investors include Ampersand Capital, Kingdom Capital, BioGenerator; 1 has since exited.

Investor typeCountShare
Venture capital450%
Private equity113%
Angel & family office113%
Other / undisclosed225%
Coming soon